Background: Bloodstream infections (BSIs) from multidrug-resistant (MDR) bacteria cause morbidity and mortality in intensive care unit (ICU) patients worldwide. This study investigated the incidence of BSIs in 5 adult general ICUs in Rome, Italy, and evaluated the mortality rate and risk factors associated with these infections. Methods: Over a 12-month period, 1,318 patients were enrolled. Demographic characteristics, Simplified Acute Physiology Score II (SAPS II), comorbidities, and BSI isolate data were collected. After stratification for the outcome, statistical analysis was performed to assess the impact of patient risk factors on in-hospital mortality. Results: There were 324 BSIs in 175 patients recorded, with an in-hospital mortality rate of 46%. Univariate analysis revealed that SAPS II, cardiac comorbidity, and Klebsiella pneumoniae BSI were significantly associated with a higher risk of death. Having a K pneumoniae BSI and cardiac illness at admission were both confirmed to be associated with death by multivariate analysis (P ¼ .0162 and P ¼ .0158, respectively). Most of the K pneumoniae isolates showed high resistance rates to carbapenems. Conclusion: BSIs caused by K pneumoniae and cardiovascular comorbidity in ICU patients are associated with a higher risk of death. Thorough surveillance for MDR pathogens and stratification of the patients' risk on admission into the ICU are key to improving the outcomes of these infections.
Bloodstream infections (BSIs) and septicemia resulting from infections with antibiotic-resistant gram-negative and grampositive bacteria are recognized as one of the most significant causes of morbidity and mortality in intensive care unit (ICU) patients worldwide. These conditions have been estimated to complicate between 1.2% and 6.7% of all ICU admissions, with a high case mortality rate of >40% in different studies. 1, 2 Globally, nearly 70% of the BSIs in ICUs are secondary to another primary infection (eg, central line, urinary or respiratory tract infections), whereas the remaining BSIs are of unknown origin. 3, 4 A recent Italian study conducted in 125 ICUs reported that BSIs, particularly catheter related-BSIs, are the second most frequent ICU-acquired infection, with an incidence of 1.9 cases per 1,000 central venous catheter days. 5 At the time of admission into the ICU, a higher Acute Physiology and Chronic Health Evaluation II or Sequential Organ Failure Assessment score, clinical presentation with septic shock or severe sepsis, multiple comorbidities (>2), and receiving inadequate antimicrobial therapy in the first 48 hours are all generally considered to be the predictors of mortality after BSI that occur in medical or ICU wards. [6] [7] [8] [9] Bacterial resistance to many antimicrobial classes, which is often encountered in the ICU environment, is nowadays a major concern for the clinician because it might be associated with increased length of hospital stay, worse outcomes, and difficulty of treatment. 10, 11 In particular, according to a recent consensus statement issued by an international panel of experts, a multidrug-resistant (MDR) pattern can be defined as nonsusceptibility to at least 1 agent in !3 antimicrobial categories, whereas an extremely drugresistant pattern is defined as nonsusceptibility to at least 1 agent in all but 2 antimicrobial categories. 12 In the EUROBACT cohort study, which included 1,156 patients from 162 ICUs in Europe, 88% of the subjects developed at least 1 episode of bacteremia, with an overall mortality rate of 35.7%, and the presence of an MDR or an extensively drug-resistant pattern in the microbiologic isolate was generally associated with a worse outcome and a higher risk of death. 13 Furthermore, over the last decade, there has been a dramatic increase in nosocomial MDR bacterial strains in the United States and Europe, particularly among isolates recovered from ICU patients. [14] [15] [16] [17] In particular, carbapenem resistance was reported in nearly 70% of Acinetobacter spp and 40% of Klebsiella spp, and an extended spectrum beta lactamases pattern was expressed in up to 30% of Enterobacteriaceae isolates globally. [18] [19] [20] The present study investigated the annual incidence of BSI in adult ICUs of 5 hospitals (3 teaching hospitals and 2 nonteaching hospitals) in Rome, Italy, in an attempt to quantify the rate of bacteremia per year, the microbiologic epidemiology and diffusion of antibiotic-resistant pathogens, and the risk factors associated with in-hospital mortality after a BSI episode.
METHODS
This was a prospective study conducted over a period of 12 months (September 2010-September 2011). Three of the hospitals involved in the study were teaching hospitals (University of Tor Vergata, University of La Sapienza, and S. Andrea Hospital), whereas 2 were nonteaching hospitals (S. Giovanni Hospital and S. Gallicano Hospital).
All patients who were admitted into the ICUs of the 5 participating hospitals, from baseline to 12 months thereafter, were enrolled in the study. Patients were enrolled regardless of the demographic characteristics and underlying clinical conditions. No exclusion criteria was provided, and no admitted patient was excluded. To collect all of the data of the enrolled patients, a database was created ad hoc. Preliminary meetings, involving the 5 participating centers, have enabled the sharing of databases for the collection of data, and the training of personnel of each center was made before enrolling patients. The preliminary meetings involved clinicians and microbiologists. On that occasion, diagnostic protocols for sample collection and laboratory microbiologic methods were shared by the participating centers. All other issues relating to data collection and statistical analysis, which emerged during the study period, were reported to the National Institute of Health, which developed the database and collaborated on the study.
All of the patients enrolled in the study were monitored daily by attending physicians for the subsequent development of BSI. According to the Centers for Disease Control and Prevention definitions for nosocomial infections, a primary BSI was considered to be the occurrence of any bacteremia not known on admission and acquired in the ICU and was defined by the isolation of !1 organism from the same patient on !1 occasion when the clinical evidence suggested signs or symptoms of sepsis. 21 An episode was considered to be a new episode when a new positive blood culture result was obtained >48 hours after a preceding positive blood culture result. Furthermore, a BSI was defined as the identification of a high-grade pathogen (eg, Pseudomonas aeruginosa, Staphylococcus aureus) in a blood culture specimen or the identification of a common contaminant or skin flora (eg, coagulase-negative staphylococci [CoNS]) in at least 2 separate blood culture specimens from the same patient. Polymicrobial bacteremia was defined as the isolation of >1 microorganism during a single bacteremic episode.
The demographic characteristics, Simplified Acute Physiology Score II (SAPS II), causes of admission, comorbidities, and BSI isolate data were collected in the database. After antimicrobial susceptibility testing, the most common patterns of drug resistance for gram-positive and gram-negative isolates were identified. Blood cultures were collected at the discretion of the attending physicians in the presence of clinical signs or symptoms of sepsis according to the surviving sepsis campaign guidelines, 22 to which all the hospitals were compliant. The cultures were processed using standard microbiologic methods. The blood cultures were performed using an automated BacT/ALERT system (bioMérieux, Durham, NC). The identification of the isolates was performed using the VITEK (bioMérieux, Durham, NC) and API automated systems (bioMérieux, Marcy l'Etoile, France). Organism identification and susceptibility classification were completed with the Vitek 2 system (bioMérieux, La-Balmes-les-Grottes, France) and by manual biochemical identification when necessary. Antimicrobial susceptibility testing was performed on all of the isolates with the Vitek 2 system, as approved by the United States Food and Drug Administration, to determine the minimal inhibitory concentrations. Organism susceptibility was interpreted according to the Clinical and Laboratory Standards Institute guidelines. 23 For the purposes of the statistical evaluation, in the cases where bacteremia was caused by >1 gram-negative isolate at the same time, the most resistant specimen was used for antimicrobial susceptibility. In all of the participating centers, an infectious diseases specialist consultation was available to manage the antimicrobial therapy of the BSI episodes along with the ICU physicians.
The study was funded by the Italian Drug Agency as part of a project aimed at monitoring the microbiologic epidemiology of Roman ICUs. The Hospital Ethical Committees of Tor Vergata University, which served as the coordinating center, approved the study. Based on the favorable opinion of the coordinating center's ethical committee, the local ethical committees endorsed the participation of each center.
Statistical analysis
The case fatality rates among all of the patients with a BSI, a polymicrobial BSI, and a monomicrobial BSI were identified and compared with the overall mortality rate for all of the causes. After stratification for the outcome (survivors vs nonsurvivors), univariate and multivariate analyses were performed to detect the most important clinical and microbiologic predictors of in-hospital mortality after acquiring a BSI in the ICU; a single analysis was also included for the most clinically important bacteria isolated from the blood cultures.
The c 2 and Fisher exact tests were used to compare the groups for the dichotomous variables, as appropriate. The t test and Mann-Whitney signed-rank test were used to compare groups for the normally and nonnormally distributed continuous variables, respectively. The variables found to be significantly associated with death in the univariate analysis were entered in a multivariable, logistic regression model, and the adjusted odds ratio (OR) and 95% confidence intervals (CIs) were calculated. The probability for removal in the logistic regression model was set at P > .10. For all of the tests, 2-tailed P values <.05 denoted statistical significance. Statistical analyses were performed using an SAS statistical package (SAS Institute, Cary, NC).
RESULTS
A total of 1,318 ICU patients were enrolled, including 841 men and 477 women, with a median age of 68 years (interquartile range, 55-77). There were 119 patients who entered the ICU from medical wards (9%), 753 from surgical wards (57.1%), 368 from emergency departments (27.9%), and 78 from other wards (6%). The most common reasons for admission into the ICU in the study population were postoperative complications (27.8%), pulmonary disease (21.09%), neurologic disease (15.02%), trauma (10.02%), gastrointestinal disease (10.02%), urinary tract disease (8.9%), and cardiovascular disease (2.28%). Other pathologies (skin and soft tissue infections, osteoarticular diseases, hematologic diseases, and others) occurred individually in 0.5%-1% of the cases (data not shown).
Overall, a total of 324 episodes of bacteremia were observed in 1 year, and 175 patients developed at least 1 episode of BSI in the ICU (13.2%), with an annual incidence rate of 132 patients per 1,000 ICU admissions. The mean time AE SD for developing an episode of a BSI after admission into the ICU was 10.4 AE 9.4 days (range, 0-51). In total, 407 isolates from 324 BSIs were collected ( Table 1 ). The microbiologic analysis of the pathogens showed that gram-positive organisms were reported in 48.6% of cases, gram-negative bacilli were reported in 43.7% and Candida spp were reported in 7.6%. Among the gram-positive cocci identified, CoNS were the most prevalent (69.1%), followed by Enterococcus spp (21.7%) and Staphylococcus aureus (6%). Among the gram-negative bacilli detected, K pneumoniae was the most common (30.8%), followed by A baumannii (28.8%), P aeruginosa (17.4%), and Escherichia coli (6.7%). The antimicrobial susceptibility patterns of the isolates collected from the blood are shown in Table 2 . On the whole, we could not observe substantial differences regarding the antimicrobial resistance rates between the 5 centers involved. Globally, we observed a high rate of oxacillin resistance among the gram-positive species (92% for the CoNS and up to 70% for the S aureus strains), whereas in the gramnegative group, a carbapenem-resistant phenotype was observed in 84%, 78%, and 48% of K pneumoniae, Acinetobacter spp, and P aeruginosa isolates, respectively. Moreover, 35% of K pneumoniae isolates and 6% of A baumannii isolates showed resistance to closeting, with a retained susceptibility to tigecycline in 89% and 81% of the isolates, respectively.
The highest percentages of patients with at least 1 episode of a BSI in the ICU were those admitted from emergency departments (52.6%) and surgical departments (28.6%) ( Table 3) . Overall, 139 out of 175 patients experienced at least 1 monomicrobial BSI, whereas 36 out of 175 experienced at least 1 episode of polymicrobial bacteremia. Among the 48 episodes of polymicrobial bacteremia, 2 episodes were composed of 4 different microbial isolates, 7 were composed of 3 different microbial isolates, and the remaining 39 episodes were composed of 2 different microbial isolates. In the subgroup of 39 polymicrobial episodes of BSI caused by 2 different microbial strains, 35.8% were caused by 2 gram-negative species (K pneumoniae plus P aeruginosa or A baumannii plus P aeruginosa),10.2% were caused by 2 gram-positive bacteria (CoNS plus Enterococcus spp), 46.1% were composed of a gram-positive and a gram-negative isolate (with the most important combination represented by Enterococcus spp plus A baumannii), and 5.1% were caused by a combination of fungal and bacterial species.
Out of 1,318 patients, 335 died, with an overall mortality rate for all causes of 25.4%. Out of 175 patients with a BSI, 82 died, with a case fatality rate for BSIs of 46% compared with 22% for those without an infection (P < .0001). The mortality rate among patients with a monomicrobial BSI was 44.4% compared with 61.1% for patients who experienced at least 1 episode of polymicrobial bacteremia. The mortality rates of patients who experienced at least 1 episode of bacteremia from K pneumoniae, A baumannii, or P aeruginosa were 67.6%, 57.5%, and 58.3%, respectively, whereas the mortality rates for BSIs caused by Staphylococcus spp (both S aureus and CoNS) and Enterococcus spp were 41% and 44.7%, respectively. BSIs caused by Candida spp were associated with a mortality rate of 47.4%.
Univariate analysis of the impact of risk factors on mortality (Table 3) showed that a higher risk of death was significantly associated with a greater illness severity at the time of admission into the ICU (SAPS II score: P ¼ .039; OR ¼ 1.03; 95% CI, 1.001-1.06), cardiac illness (P ¼ .015; OR ¼ 2.5; 95% CI, 1.20-5.42), and episodes of bacteremia caused by K pneumoniae (P ¼ .005; OR ¼ 2.96; 95% CI, 1.37-6.37). Moreover, a tendency for a higher risk of death was detected in patients who experienced at least 1 episode of polymicrobial bacteremia; however, this increased risk did not reach statistical significance (P ¼ .057; OR ¼ 2.07; 95% CI, 0.98-4.38). The multivariate analysis (Table 4 ) confirmed that having a BSI caused by K pneumoniae and presenting with a cardiac illness at the time of admission into the ICU were independently associated with a higher mortality rate (P ¼ .0162 and P ¼ .0158, respectively). 
DISCUSSION
BSI, severe sepsis, and septic shock are usually recognized as important causes of morbidity and mortality in the ICU. In our study, we observed a BSI annual incidence rate of 132 patients per 1,000 ICU admissions, which is in accordance with rates reported in previous studies. 1 In our microbiologic analysis, we observed a slightly higher prevalence of gram-positive species (48.6%) over gram-negative species (43.7%); however, we detected higher mortality rates in the patients with BSIs caused by gram-negative bacteria, with a maximum rate of 67.6% in the patients who experienced at least 1 episode of BSI caused by K pneumoniae strains.
Among the gram-negative bacilli detected, we found an important increase in the carbapenemase-producing phenotypes (up to 85% of all of the isolates), as observed in the recent epidemic of Klebsiella pneumoniae carbapenemase (KPC)-producing K pneumoniae strains in Italy, Greece, and other South European countries 24 ; moreover, up to 30% of the strains of K pneumoniae were colistin resistant. We also noted an increase in resistance to Table 2 Frequency of resistance to the main antimicrobial classes among the most relevant gram-negative and gram-positive isolates from bloodstream infections according to the Clinical and Laboratory Standards Institute breakpoints 23 Gram-negative (n)  AMK  GEN  AMOX  CEFT  CTX  TZP  MER  IMP  COLI  LVX  CIP  SXT  TIGE   Klebsiella pneumoniae (55)  82  11  80  89  89  90  84  79  35  96  94  72  11  Acinetobacter baumannii (50)  59  96  100  93  93  94  78  86  6  94  96  95  19  Pseudomonas aeruginosa (31)  3  35  100  32  92  33  48  45  0  50  42 carbapenems in P aeruginosa and A baumannii isolates (up to 45% and 86% of all of the strains, respectively). The dramatic increase in carbapenem-resistant strains of K pneumoniae in the ICU may account for the higher rate of mortality in patients who experienced a BSI episode caused by these species because these infections may be associated with ineffective empirical antimicrobial therapy in the first 48 hours after the diagnosis and poor clinical outcomes. [25] [26] [27] [28] According to different studies, experiencing an episode of BSI in the ICU is significantly associated with higher rates of in-hospital mortality. 1, 2 In our study, developing a BSI in the ICU was associated with a 20.6% increase in in-hospital mortality (from 25.4%-46%), which is similar to the findings of other reports. In a meta-analysis that included 30 studies of the predictors of mortality for nosocomial infections caused by MDR gram-negative bacteria, Vardakas et al found that septic shock, length of ICU stay, pneumonia, isolation of MDR species, inappropriate empirical and definitive therapy, and male sex were associated with increased mortality, whereas polymicrobial infections and cancer were not associated with death. 30 In contrast, our univariate analysis detected a tendency toward an association between polymicrobial BSIs, SAPS II, and in-hospital mortality; in the multivariate analysis, heart disease and having a BSI from K pneumoniae were significantly associated with death. We did not detect significant associations with death for cancer, hypertension, diabetes, renal failure, chronic obstructive pulmonary disease, male sex, postsurgical admission, trauma and mortality, and other noneK pneumoniae bacterial isolates, including carbapenem-resistant Acinetobacter spp and Pseudomonas spp.
Some limitations of our study should be mentioned. For instance, as a consequence of the great variability of the causative pathogens in our cohort, frequent overlapping infectious events occurring in the ICU environment, and polymicrobial nature of the BSI events in certain circumstances, we could not provide complete and uniform data concerning the antibiotic treatments adopted in each episode of BSI and the timing of antibiotic administration. As a result, even though the identification of the antimicrobial strategies was beyond the aim of our study, we cannot furnish reliable information about a possible correlation between mortality and empirical antibiotic treatment. Moreover, carbapenem resistance in the K pneumoniae strains was only phenotypically determined because genotypic assays to identify the KPC genes and other metallo-b-lactamases subtypes were not available in all the centers involved.
However, our study showed that the identification of the causative organisms for BSI episodes may be relevant for predicting outcomes because we observed a significant trend toward a higher risk of death in patients with polymicrobial bacteremia, especially in the context of infections caused by MDR gram-negative bacilli, such as the recently reported carbapenem-resistant K pneumoniae strains. Moreover, high SAPS II at the time of admission or the presence of heart disease may help to predict mortality in ICU patients with BSI. Therefore, more thorough evaluations of the illness severity status, cardiac status, and risk factors of the patient on admission into the ICU may be useful in both estimating survival rates and implementing optimal surveillance protocols for these nosocomial infections. 
